| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +8% |
| 3Y CAGR | +3% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +311% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,376.10 +13.30 (0.56%) | 17,958.14 | 26.49 | 5.33 | ||
PfizerPFIZER | ₹3,759.80 +25.40 (0.68%) | 17,040.57 | 23.18 | 4.05 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,299.00 +62.00 (0.99%) | 15,586.75 | 91.89 | 17.86 | ||
Natco PharmaNATCOPHARM | ₹787.55 -5.45 (0.69%) | 15,562.98 | 13.6 | 1.48 |